14th February 2024

Oncologists are developing a new blood test to assess patients developing gastric cancer recurrence. 2,000 patients were recruited into the study.

Oncologists are developing a new blood test to assess patients developing gastric cancer recurrence. 2,000 patients were recruited into the study. 400 patients with confirmed gastric cancer and 1600 control subjects were included in the study. 80 patients with gastric cancer and 1400 control subjects tested negative for the test.  

What is the specificity of the test?